Jaume Mora is a pediatric oncologist who gained his PhD in molecular oncology in 2003. After residency training in general pediatrics (1992–1995), he completed a pediatric hematology and oncology fellowship at MSKCC in New York (1996–1998). He completed three years of research fellowship in molecular pathology, also at MSKCC (1999–2001). In 2002, he returned to Barcelona as the leader of the Pediatric Oncology Department at Hospital Sant Joan de Déu (HSJD) and founded the Developmental Tumor Biology Laboratory. From 2007 to 2012, he was the head of the Pediatric Oncology Department. Since 2013, he has been the scientific director of the Pediatric Cancer Center Barcelona (PCCB) at HSJD. His research focuses on the origin of childhood tumors with contributions in neuroblastoma, Ewing sarcoma, retinoblastoma, Wilms’s tumor, and DIPG. He was distinguished with the American Society of Clinical Oncology (ASCO) Young Investigator Award (YIA) in 2000, the 16th Schweisguth Prize of the International Society of Pediatric Oncology (SIOP) in 2001, and the ASCO Career Development Award in 2001. He won the first research grant for pediatric oncology of the Spanish Association against Cancer (AECC) in 2006, the first research award in translational oncology of the FERO Society in 2009, and the first Martí Via award in translational oncology of the Fundació Vallformosa in 2015.
Jaume Mora is a pediatric oncologist who gained his PhD in molecular oncology in 2003. After residency training in general pediatrics (1992–1995), he completed a pediatric hematology and oncology fellowship at MSKCC in New York (1996–1998). He completed three years of research fellowship in molecular pathology, also at MSKCC (1999–2001). In 2002, he returned to Barcelona as the leader of the Pediatric Oncology Department at Hospital Sant Joan de Déu (HSJD) and founded the Developmental Tumor Biology Laboratory. From 2007 to 2012, he was the head of the Pediatric Oncology Department. Since 2013, he has been the scientific director of the Pediatric Cancer Center Barcelona (PCCB) at HSJD. His research focuses on the origin of childhood tumors with contributions in neuroblastoma, Ewing sarcoma, retinoblastoma, Wilms’s tumor, and DIPG. He was distinguished with the American Society of Clinical Oncology (ASCO) Young Investigator Award (YIA) in 2000, the 16th Schweisguth Prize of the International Society of Pediatric Oncology (SIOP) in 2001, and the ASCO Career Development Award in 2001. He won the first research grant for pediatric oncology of the Spanish Association against Cancer (AECC) in 2006, the first research award in translational oncology of the FERO Society in 2009, and the first Martí Via award in translational oncology of the Fundació Vallformosa in 2015.